hCD19/hCD3EDG(BALB/c)
Nomenclature
BALB/cAnSmoc-Cd19em(hCD19)Cd3etm1(hCD3E)Cd3dtm1(hCD3D)Cd3gtm1(hCD3G)Smoc
Cat. NO.
NM-XA-240066
Strain State
Embryo cryopreservation
Model Description
Validation Data
Fig.1 Detection of immune phenotype in WT BALB/c and HO/HO hCD3EDG/hCD19 mice.(male, n=3)
Fig.2 Detection of phenotype in Peripheral blood in WT BALB/c and HO/HO hCD3EDG/hCD19 mice.
Fig.3 Detection of phenotype in Spleen in WT BALB/c and HO/HO hCD3EDG/hCD19 mice.
Fig.4 Detection of phenotype in Lymph node in WT BALB/c and HO/HO hCD3EDG/hCD19 mice.
Fig.5 Blinatumomab injections were repeated daily for 5 days and immune cells in the PB of mice after therapy were measured by flow cytometry(n=6). Average ± SEM;*P<0.05,**P<0.01,***P<0.001;(Student' s t test)
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more